AHIP Comments on the proposed rule on Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, published in the Federal Register on March 1, 2023.
Overview
AHIP strongly supports the use of telemedicine and our members are committed to expanding access to virtual care. While we appreciate the Drug Enforcement Administration’s (DEA’s) efforts to balance patient access with patient safety, we are concerned that the proposed rule may erect barriers to further innovation in health care and offer several recommendations for consideration.